跳至主要内容
临床试验/NCT00509392
NCT00509392已完成4 期

Radiofrequency Endovenous ClosureFAST vs. Laser Ablation for the Treatment of Great Saphenous Reflux: A Multicenter, Single-Blinded, Randomized Study (RECOVERY)

Medtronic Endovascular1 个研究点 分布在 1 个国家目标入组 69 人开始时间: 2007年3月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
69
试验地点
1
主要终点
Ecchymosis

研究概览

简要总结

The objective of this post-market study is to compare the post-procedure recovery between two types of minimally invasive catheter treatments for venous disease in the Great Saphenous Vein.

详细描述

Comparison of the post-procedure recovery of radiofrequency (RFA) treatment vs. laser treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •All subjects must provide written informed consent.
  • •Must be a candidate for either treatment with Radiofrequency Ablation (RFA) or endovenous laser.

排除标准

  • •Subjects who require additional treatments in either leg within 30 days before or after the study procedure.
  • •Subjects who are participating in another investigational study.

研究组 & 干预措施

Seg. RF Ablation & ClosureFAST catheter

Active Comparator

Seg. RF Ablation & ClosureFAST catheter

干预措施: Seg. RF Ablation & ClosureFAST catheter (Device)

Endovenous Laser

Active Comparator

Treatment invention of venous disease with an Endovenous Laser.

干预措施: Endovenous Laser (Device)

结局指标

主要结局

Ecchymosis

时间窗: 1 Month post treatment (no baseline)

0-5 scale (5 most severe) 0: None 1. \<25% 2. 25-50% 3. 50-75% 4. 75-100% 5. Above or below tx segment

Pain

时间窗: 1 Month

Pain 0-10 scale (10 most severe)

Complications

时间窗: 1 month

Sequelae at any follow-up

Tenderness

时间窗: 1 Month

Tenderness 0-10 scale (10 most severe)

Tenderness

时间窗: 2 Weeks

Tenderness 0-10 scale (10 most severe)

Pain

时间窗: 48 Hour

Pain 0-10 scale (10 most severe)

Pain

时间窗: 1 Week

Pain 0-10 scale (10 most severe)

Pain

时间窗: 2 Weeks

Pain 0-10 scale (10 most severe)

Tenderness

时间窗: 48 Hour

Tenderness 0-10 scale (10 most severe)

Tenderness

时间窗: 1 Week

Tenderness 0-10 scale (10 most severe)

Ecchymosis

时间窗: 48 Hours post treatment (no baseline)

0-5 scale (5 most severe) 0: None 1. \<25% 2. 25-50% 3. 50-75% 4. 75-100% 5. Above or below treated (tx) segment

Ecchymosis

时间窗: 1 Week post treatment (no baseline)

0-5 scale (5 most severe) 0: None 1. \<25% 2. 25-50% 3. 50-75% 4. 75-100% 5. Above or below tx segment

Ecchymosis

时间窗: 2 Weeks post treatment (no baseline)

0-5 scale (5 most severe) 0: None 1. \<25% 2. 25-50% 3. 50-75% 4. 75-100% 5. Above or below tx segment

次要结局

  • Change in CIVIQ QOL(1 Month)
  • VCSS(1 Month)
  • VCSS(48 Hours)
  • VCSS(1 Week)
  • VCSS(2 Weeks)
  • Change in CIVIQ QOL(48 Hours)
  • Change in CIVIQ QOL(1 Week)
  • Change in CIVIQ QOL(2 Week)

研究者

发起方
Medtronic Endovascular
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验